← brief for 2026-10-19 · Slowing decline

Selective Prescribing of First‐Line SGLT2 Inhibitor and GLP‐1 RA in Adults With Severe Mental Illness and Type 2 Diabetes

Article No results yet Peer reviewed

Key takeaways

Who did this work

Chiang Y (University of Maryland School of Pharmacy) · Chen C (University of Maryland School of Medicine) · Li X (Harvard Medical School and Harvard Pilgrim Health Care Institute) · Rochester‐Eyeguokan C (University of Maryland School of Pharmacy) · Castillo W (University of Maryland School of Pharmacy) · dosReis S (University of Maryland School of Pharmacy)

Source

Article · Europe PMC, CKD · 2026-10-18
https://europepmc.org/article/PMC/PMC13677212